Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis

Howell I. et al, (2024)

Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23

Cane J. et al, (2023)

Additional effects of oral prednisolone following mepolizumab on the nasal transcriptome

Howell I. et al, (2023), Airway cell biology and immunopathology

Method development for flow-cytometric analysis of primary human airway epithelia infected with non-typeable Haemophilus influenzae

Horton KL. et al, (2022), 03.02 - Airway cell biology and immunopathology

Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies

Jabeen MF. et al, (2022), Microbiology Spectrum, 10

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Hinks TSC. et al, (2021), The Lancet Respiratory Medicine, 9, 1130 - 1140

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells

Zhuang X. et al, (2021), iScience, 24, 103144 - 103144

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan S. et al, (2021), Respiratory infections and bronchiectasis

Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection

Lababidi R. et al, (2021), Mechanisms of lung injury and repair

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1

Cane JL. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 1437 - 1447

A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial

Hinks TSC. et al, (2021), SSRN Electronic Journal

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Ramakrishnan S. et al, (2021), The Lancet Respiratory Medicine

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells

Zhuang X. et al, (2021)

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan S. et al, (2021)

Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial

Ramakrishnan S. et al, (2021)

A RANDOMISED CLINICAL TRIAL OF AZITHROMYCIN VERSUS STANDARD CARE IN AMBULATORY COVID-19-THE ATOMIC2 TRIAL

Hinks TSC. et al, (2021), THORAX, 76, A35 - A35

Interferon responses are dysfunctional in the epithelium of COPD Patients

Lababidi R. et al, (2020), Airway cell biology and immunopathology

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease

Thulborn SJ. et al, (2020), International Journal of Chronic Obstructive Pulmonary Disease, Volume 15, 1357 - 1365

Epithelial Cell Regulation of Type 2 Cytokine Release by Peripheral Blood Mononuclear Cells

Southern A. et al, (2020)

Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD

Thulborn SJ. et al, (2020), European Respiratory Journal, 55, 1902412 - 1902412

Load More

Include forthcoming?